Skip to content
City PM
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Opinion
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Opinion
Wednesday 28 January 2015 8:56 pm

Ebola cure call lifts final quarter tallies for Irn-Bru drinks-maker AG Barr

By: Express KCS

Add as a preferred source on Google

The maker of Scotland’s “other national drink” Irn-Bru reported five per cent sales growth in its final quarter of its financial year.

In the three months to 25 January the producer AG Barr said trading performance is expected to have been well ahead of total soft drinks market.

Full year revenue is expected to be around £259m, a year-on-year growth of close to two per cent.

Chief executive Roger White said sales were boosted in the final days of the year when it emerged Scottish nurse Pauline Cafferkey who survived Ebola praised Irn-Bru as a key part of her recovery from the virus.

The media coverage added to the publicity for the brand, which also had a sponsorship deal with the Glasgow Commonwealth Games.

AG Barr said it remained on course to profit expectations.

The company had a merger proposal rejected from larger British rival Britvic in July 2013.

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • News

Categories

  • Tech

Related Topics

  • Barr (A.G.)
  • Company
  • Ebola

Trending Articles

  • Brewdog chief executive quits after only one year

  • Burnham tax plans spark investor rush to bank capital gains

  • Housebuilding giants hit with £4.5bn lawsuit for allegedly overcharging buyers

  • UK ‘no longer a serious place’ says Hedge fund boss after losing £200m tax battle

  • Canary Wharf’s reinvention is a triumph

More from City PM

  • Curatis Increases Revenue Growth Guidance for 2026

    Business Wire
  • Bitcoin Suisse Receives MiCAR License and Launches European Expansion

    Business Wire
  • Araris Biotech AG and Taiho Oncology Announce Dosing of First Patient in Phase 1 Trial of ARC-02, a Novel ADC for the Treatment of Non-Hodgkin Lymphoma

    Business Wire
  • GSK shares slip after buying US cancer treatment firm Nuvalent for $10.6bn

    Pharma
    GSK logo displayed prominently, signifying the companys presence and relevance in the business and healthcare sectors.
  • Delaying estate planning could cost affluent Brits over £12bn

    Personal Finance
    Reeves is reportedly considering a range of property taxes
  • Rehlko and Liebherr Partner on Strategic Capacity Expansion to Support Accelerating Data Center Demand for Resilient Power Solutions

    Business Wire
  • LR Health & Beauty SE Successfully Completes Financial Realignment – Strong Foundation for Growth and Long-Term Partnerships

    Business Wire
  • Linvo Sets Sights on AI-Led Wealth Management, Opens AI Advisor Roles for 2026

    Business Wire

City PM — European politics, business and analysis.

Europe

  • Germany
  • France
  • Europe
  • UK & Ireland

Topics

  • Business
  • Markets
  • AI
  • Technology
  • Opinion
  • Energy

More

  • Politics
  • Economics
  • Fintech
  • Legal
  • Sport
  • Life

Company

  • About City PM
  • Editorial Policy
  • Corrections
  • Contact
  • Terms of Use
  • Privacy Policy
  • Cookie Policy
© 2026 City PM · Published by CityPM Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
About · Editorial Policy · Corrections · Contact · Privacy